Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IV Randomized, Blinded Clinical Trial to Assess Measles Mumps and Rubella Combined Vaccine, Live, (MMR) Lot-to-lot Consistency in Healthy Chinese Children at the Age of 8-12 Months

NCT05161845 is registered in ClinicalTrials.gov with Shanghai Institute Of Biological Products as lead sponsor.

NCT NCT05161845
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05161845 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IV Randomized, Blinded Clinical Trial to Assess Measles Mumps and Rubella Combined Vaccine, Live, (MMR) Lot-to-lot Consistency in Healthy Chinese Children at the Age of 8-12 Months
Lead sponsor
Shanghai Institute Of Biological Products
Phase
Phase 4
Overall status
Completed
Start date
December 23, 2021
Completion date
October 1, 2022
Enrollment
1,068 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

immunotoxicity, vaccine